Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Harvoni immune effects in HCV+ IDUs
NCT02347345Phase 4Completed
- Sponsor
- The Rockefeller University
- Start
- Nov 2016
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ledipasvir in hepatitis C (HCV), sponsored by The Rockefeller University. Started Nov 2016; status: completed.
02
Drugs
ledipasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02347345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02347345.